西方石油Q2盈利不及預期 回購巴菲特所持5.22億美元優先股
格隆匯8月3日丨西方石油於美股盤後公佈2023年Q2業績,營收67.31億美元,同比下降37%,低於分析師預期的66.85億美元;淨利潤6.05億美元,同比大幅下降83%,低於預期7.6億美元。第二季度產量達120萬桶油當量/天,同比增長6%;油氣銷售額下降36%,至49.4億美元。此外,公司從伯克希爾哈撒韋公司回購5.22億美元的優先股,今年贖回額達12億美元,相當於伯克希爾最初100億美元投資的12%。指引方面,公司將全年產量目標從119.5萬桶/天上調至119萬桶-124萬桶/天之間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.